首页> 美国卫生研究院文献>Plastic and Reconstructive Surgery Global Open >Novel Forehead Augmentation Strategy: Forehead Depression Categorization and Calcium-Hydroxyapatite Filler Delivery after Tumescent Injection
【2h】

Novel Forehead Augmentation Strategy: Forehead Depression Categorization and Calcium-Hydroxyapatite Filler Delivery after Tumescent Injection

机译:新颖的前额增强策略:肿胀注射后前额抑郁症的分类和钙-羟基磷灰石填充剂的输送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:The minimally invasive delivery of soft-tissue calcium hydroxyapatite fillers can ameliorate the appearance of forehead depressions and wrinkles. Forehead augmentations using fillers lead to fewer adverse events and to a faster recovery time than those using surgical procedures. However, many physicians avoid using them due to the risk of pain, intravascular injections, and embolisms that can cause skin necrosis and blindness. Strategy to address these issues includes pain reduction through tumescent solution before filler injection considering the vascular pathway. In addition, the strategy is also safer from embolism.
机译:背景:软组织羟基磷灰石钙填充剂的微创递送可改善前额凹陷和皱纹的外观。与使用外科手术的人相比,使用填充物的前额增强术可减少不良事件并缩短恢复时间。但是,由于可能引起皮肤坏死和失明的疼痛,血管内注射和栓塞的危险,许多医生避免使用它们。解决这些问题的策略包括考虑血管途径,在填充剂注射之前通过肿胀溶液减轻疼痛。此外,该策略也更安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号